• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于扩散加权成像的乳腺癌远处无病生存预测生物标志物。

Biomarkers Predictive of Distant Disease-free Survival Derived from Diffusion-weighted Imaging of Breast Cancer.

机构信息

Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine.

Department of Diagnostic Radiology, Kansai Electric Power Hospital.

出版信息

Magn Reson Med Sci. 2023 Oct 1;22(4):469-476. doi: 10.2463/mrms.mp.2022-0060. Epub 2022 Aug 3.

DOI:10.2463/mrms.mp.2022-0060
PMID:35922924
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10552669/
Abstract

PURPOSE

To investigate whether intravoxel incoherent motion (IVIM) and/or non-Gaussian diffusion parameters are associated with distant disease-free survival (DDFS) in patients with invasive breast cancer.

METHODS

From May 2013 to March 2015, 101 patients (mean age 60.0, range 28-88) with invasive breast cancer were evaluated prospectively. IVIM parameters (flowing blood volume fraction [f] and pseudodiffusion coefficient [D*]) and non-Gaussian diffusion parameters (theoretical apparent diffusion coefficient [ADC] at a b value of 0 s/mm [ADC] and kurtosis [K]) were estimated using a diffusion-weighted imaging series of 16 b values up to 2500 s/mm. Shifted ADC values (sADC) and standard ADC values (ADC) were also calculated. The Kaplan-Meier method was used to generate survival analyses for DDFS, which were compared using the log-rank test. Univariable Cox proportional hazards models were used to assess any associations between each parameter and distant metastasis-free survival.

RESULTS

The median observation period was 80 months (range, 35-92 months). Among the 101 patients, 12 (11.9%) developed distant metastasis, with a median time to metastasis of 79 months (range, 10-92 months). Kaplan-Meier analysis showed that DDFS was significantly shorter in patients with K > 0.98 than in those with K ≤ 0.98 (P = 0.04). Cox regression analysis showed a marginal statistical association between K and distant metastasis-free survival (P = 0.05).

CONCLUSION

Non-Gaussian diffusion may be associated with prognosis in invasive breast cancer. A higher K may be a marker to help identify patients at an elevated risk of distant metastasis, which could guide subsequent treatment.

摘要

目的

研究体素内不相干运动(IVIM)和/或非高斯扩散参数与浸润性乳腺癌患者无远处疾病生存(DDFS)的关系。

方法

2013 年 5 月至 2015 年 3 月,前瞻性评估了 101 例浸润性乳腺癌患者(平均年龄 60.0 岁,范围 28-88 岁)。使用 16 个 b 值(0 s/mm2 至 2500 s/mm2)的扩散加权成像序列估计 IVIM 参数(血流分数 [f]和假性扩散系数 [D*])和非高斯扩散参数(理论表观扩散系数 [ADC]在 b 值为 0 s/mm2时[ADC]和峰度 [K])。还计算了移位 ADC 值(sADC)和标准 ADC 值(ADC)。Kaplan-Meier 法用于生成 DDFS 的生存分析,并使用对数秩检验进行比较。单变量 Cox 比例风险模型用于评估每个参数与无远处转移生存之间的任何关联。

结果

中位观察期为 80 个月(范围 35-92 个月)。在 101 例患者中,12 例(11.9%)发生远处转移,中位转移时间为 79 个月(范围 10-92 个月)。Kaplan-Meier 分析显示,K 值>0.98 的患者的 DDFS 明显短于 K 值≤0.98 的患者(P=0.04)。Cox 回归分析显示 K 与无远处转移生存之间存在边缘统计学关联(P=0.05)。

结论

非高斯扩散可能与浸润性乳腺癌的预后相关。较高的 K 值可能是识别远处转移风险较高的患者的标志物,有助于指导后续治疗。

相似文献

1
Biomarkers Predictive of Distant Disease-free Survival Derived from Diffusion-weighted Imaging of Breast Cancer.基于扩散加权成像的乳腺癌远处无病生存预测生物标志物。
Magn Reson Med Sci. 2023 Oct 1;22(4):469-476. doi: 10.2463/mrms.mp.2022-0060. Epub 2022 Aug 3.
2
Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions.体素内不相干运动和定量非高斯扩散磁共振成像:评估几种良恶性乳腺病变标志物的诊断和预后价值。
Radiology. 2018 May;287(2):432-441. doi: 10.1148/radiol.2017162853. Epub 2017 Nov 2.
3
Variability of non-Gaussian diffusion MRI and intravoxel incoherent motion (IVIM) measurements in the breast.乳腺中非高斯扩散 MRI 和体素内不相干运动(IVIM)测量的可变性。
PLoS One. 2018 Mar 1;13(3):e0193444. doi: 10.1371/journal.pone.0193444. eCollection 2018.
4
Quantitative non-Gaussian diffusion and intravoxel incoherent motion magnetic resonance imaging: differentiation of malignant and benign breast lesions.定量非高斯扩散与体素内不相干运动磁共振成像:乳腺良恶性病变的鉴别
Invest Radiol. 2015 Apr;50(4):205-11. doi: 10.1097/RLI.0000000000000094.
5
Intravoxel Incoherent Motion Diffusion-weighted MRI of Infiltrated Marrow for Predicting Overall Survival in Newly Diagnosed Acute Myeloid Leukemia.浸润性骨髓内体素内不相干运动弥散加权 MRI 预测初诊急性髓系白血病的总生存期
Radiology. 2020 Apr;295(1):155-161. doi: 10.1148/radiol.2020191693. Epub 2020 Feb 18.
6
Intravoxel incoherent motion (IVIM) and non-Gaussian diffusion MRI of the lactating breast.哺乳期乳腺的体素内不相干运动(IVIM)和非高斯扩散磁共振成像
Eur J Radiol Open. 2018 Feb 2;5:24-30. doi: 10.1016/j.ejro.2018.01.003. eCollection 2018.
7
Intravoxel incoherent motion diffusion-weighted MRI of invasive breast cancer: Correlation with prognostic factors and kinetic features acquired with computer-aided diagnosis.浸润性乳腺癌体素内不相干运动扩散加权 MRI:与预后因素及计算机辅助诊断获得的动力学特征的相关性。
J Magn Reson Imaging. 2019 Jan;49(1):118-130. doi: 10.1002/jmri.26221. Epub 2018 Sep 20.
8
Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival.扩散加权成像在浸润性乳腺癌中的应用:与远处无转移生存的关系。
Radiology. 2019 May;291(2):300-307. doi: 10.1148/radiol.2019181706. Epub 2019 Mar 12.
9
Apparent diffusion coefficient and intravoxel incoherent motion-diffusion kurtosis model parameters in invasive breast cancer: Correlation with the histological parameters of whole-slide imaging.浸润性乳腺癌的表观扩散系数和体素内不相干运动-扩散峰度模型参数:与全切片成像组织学参数的相关性
Magn Reson Imaging. 2022 Jul;90:53-60. doi: 10.1016/j.mri.2022.04.003. Epub 2022 Apr 16.
10
The value of intravoxel incoherent motion model-based diffusion-weighted imaging for predicting long-term outcomes in nasopharyngeal carcinoma.基于体素内不相干运动模型的扩散加权成像在预测鼻咽癌长期预后中的价值。
Front Oncol. 2022 Dec 1;12:902819. doi: 10.3389/fonc.2022.902819. eCollection 2022.

引用本文的文献

1
Evaluation of lncRNAs as Potential Biomarkers for Diagnosis of Metastatic Triple-Negative Breast Cancer through Bioinformatics and Machine Learning.通过生物信息学和机器学习评估长链非编码RNA作为转移性三阴性乳腺癌诊断潜在生物标志物的研究
Iran J Biotechnol. 2024 Jul 1;22(3):e3853. doi: 10.30498/ijb.2024.432171.3853. eCollection 2024 Jul.
2
Standardization and advancements efforts in breast diffusion-weighted imaging.乳腺扩散加权成像的标准化及进展工作
Jpn J Radiol. 2025 Mar;43(3):347-354. doi: 10.1007/s11604-024-01696-z. Epub 2024 Dec 6.
3
Advanced breast diffusion-weighted imaging: what are the next steps? A proposal from the EUSOBI International Breast Diffusion-weighted Imaging working group.

本文引用的文献

1
Evaluation of suspicious breast lesions with diffusion kurtosis MR imaging and connection with prognostic factors.弥散峰度磁共振成像评价可疑乳腺病变及其与预后因素的相关性。
Eur J Radiol. 2021 Dec;145:110014. doi: 10.1016/j.ejrad.2021.110014. Epub 2021 Oct 31.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Repeatability of IVIM biomarkers from diffusion-weighted MRI in head and neck: Bayesian probability versus neural network.
晚期乳腺扩散加权成像:下一步该怎么做?欧洲乳腺影像学会国际乳腺扩散加权成像工作组的提议
Eur Radiol. 2025 Apr;35(4):2130-2140. doi: 10.1007/s00330-024-11010-0. Epub 2024 Oct 8.
4
Diffusion-Weighted MRI for the Assessment of Molecular Prognostic Biomarkers in Breast Cancer.扩散加权磁共振成像在乳腺癌分子预后生物标志物评估中的应用。
Korean J Radiol. 2024 Jul;25(7):623-633. doi: 10.3348/kjr.2023.1188.
5
Mean Apparent Propagator MRI: Quantitative Assessment of Tumor-Stroma Ratio in Invasive Ductal Breast Carcinoma.平均表观弥散系数 MRI:浸润性导管乳腺癌肿瘤-基质比的定量评估。
Radiol Imaging Cancer. 2024 Jul;6(4):e230165. doi: 10.1148/rycan.230165.
6
Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study.缺氧肿瘤微环境的非增强多参数磁共振成像可实现乳腺癌分子亚型分类:一项初步研究
Cancers (Basel). 2024 Jan 16;16(2):375. doi: 10.3390/cancers16020375.
7
Diffusion kurtosis imaging as a biomarker of breast cancer.扩散峰度成像作为乳腺癌的生物标志物
BJR Open. 2023 Jan 14;5(1):20220038. doi: 10.1259/bjro.20220038. eCollection 2023.
8
Diagnostic performance of mono-exponential DWI versus diffusion kurtosis imaging in breast lesions: A meta-analysis.单指数 DWI 与扩散峰度成像在乳腺病变中的诊断性能:荟萃分析。
Medicine (Baltimore). 2022 Nov 4;101(44):e31574. doi: 10.1097/MD.0000000000031574.
头颈部扩散加权磁共振成像中IVIM生物标志物的可重复性:贝叶斯概率与神经网络
Magn Reson Med. 2021 Jun;85(6):3394-3402. doi: 10.1002/mrm.28671. Epub 2021 Jan 26.
4
The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis.扩散峰度成像在乳腺肿瘤特征描述中的诊断效能:一项Meta分析
Front Oncol. 2020 Oct 27;10:575272. doi: 10.3389/fonc.2020.575272. eCollection 2020.
5
Distant metastasis prediction via a multi-feature fusion model in breast cancer.通过多特征融合模型预测乳腺癌远处转移
Aging (Albany NY). 2020 Sep 28;12(18):18151-18162. doi: 10.18632/aging.103630.
6
Heterogeneity of enhancement kinetics in dynamic contrast-enhanced MRI and implication of distant metastasis in invasive breast cancer.动态对比增强 MRI 强化动力学的异质性及其对浸润性乳腺癌远处转移的意义。
Clin Radiol. 2020 Dec;75(12):961.e25-961.e32. doi: 10.1016/j.crad.2020.07.030. Epub 2020 Aug 25.
7
Perfusion-driven Intravoxel Incoherent Motion (IVIM) MRI in Oncology: Applications, Challenges, and Future Trends.灌注驱动的体素内不相干运动(IVIM)磁共振成像在肿瘤学中的应用、挑战与未来趋势。
Magn Reson Med Sci. 2021 Jun 1;20(2):125-138. doi: 10.2463/mrms.rev.2019-0124. Epub 2020 Jun 15.
8
Breast cancer recurrence risk prediction using whole-lesion histogram analysis with diffusion kurtosis imaging.基于扩散峰度成像的全病变直方图分析预测乳腺癌复发风险。
Clin Radiol. 2020 Mar;75(3):239.e1-239.e8. doi: 10.1016/j.crad.2019.10.015. Epub 2019 Nov 22.
9
Diffusion MRI of the breast: Current status and future directions.乳腺弥散磁共振成像:现状与未来方向。
J Magn Reson Imaging. 2020 Jul;52(1):70-90. doi: 10.1002/jmri.26908. Epub 2019 Sep 14.
10
Optimal b-values for diffusion kurtosis imaging in invasive ductal carcinoma versus ductal carcinoma in situ breast lesions.浸润性导管癌与乳腺导管原位癌病变中扩散峰度成像的最佳b值
Australas Phys Eng Sci Med. 2019 Sep;42(3):871-885. doi: 10.1007/s13246-019-00773-2. Epub 2019 Jul 18.